Is calprotectin a marker of tobacco smoke related inflammation: A pilot study in children

Inhalation Toxicology

Volumn 24, Issue 8, 2012, Pages 486-491

  Cobanoglu, Nazan ^a   Dalkan, Ceyhun ^a   Galip, Nilufer ^a   Tekguc, Hakan ^a   Uncu, Murat ^a   Bahceciler, Nerin N ^a  

^a NEAR EAST UNIVERSITY   (Turkey)

Author keywords

Calprotectin; Ghrelin; Inflammation; Leptin; Smoke exposure

Indexed keywords

CALGRANULIN; GHRELIN; LEPTIN;

ARTICLE; BODY MASS; CHILD; CHILDHOOD DISEASE; CONTROLLED STUDY; DISEASE MARKER; FEMALE; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; PARENTAL SMOKING; PILOT STUDY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; QUESTIONNAIRE; SCHOOL CHILD;

AIR POLLUTION, INDOOR; BIOLOGICAL MARKERS; BODY MASS INDEX; CHILD; CROSS-SECTIONAL STUDIES; DATA INTERPRETATION, STATISTICAL; FEMALE; HUMANS; INFLAMMATION; LEUKOCYTE L1 ANTIGEN COMPLEX; MALE; PILOT PROJECTS; QUESTIONNAIRES; TOBACCO SMOKE POLLUTION;

NICOTIANA TABACUM;

EID: 84863309727     PISSN: 08958378     EISSN: 10917691     Source Type: Journal    
DOI: 10.3109/08958378.2012.693137     Document Type: Article

References (36)

1. Albanes D, Jones DY, Micozzi MS, Mattson ME. 1987. Associations between smoking and body weight in the US population: analysis of NHANES II. Am J Public Health 77:439-444. (Pubitemid 17044057)
2. Bouloumié A, Drexler HC, Lafontan M, Busse R. 1998. Leptin, the product of Ob gene, promotes angiogenesis. Circ Res 83:1059-1066. (Pubitemid 28520935)
3. Bouros D, Tzouvelekis A, Anevlavis S, Doris M, Tryfon S, Froudarakis M, Zournatzi V, Kukuvitis A. 2006. Smoking acutely increases plasma ghrelin concentrations. Clin Chem 52:777-778.
4. Broekhuizen R, Vernooy JH, Schols AM, Dentener MA, Wouters EF. 2005. Leptin as local inflammatory marker in COPD. Respir Med 99:70-74. (Pubitemid 40017387)
5. Canoy D, Wareham N, Luben R, Welch A, Bingham S, Day N, Khaw KT. 2005. Cigarette smoking and fat distribution in 21,828 British men and women: a population-based study. Obes Res 13:1466-1475.
6. Chen H, Hansen MJ, Jones JE, Vlahos R, Anderson GP, Morris MJ. 2008. Long-term cigarette smoke exposure increases uncoupling protein expression but reduces energy intake. Brain Res 1228:81-88.
7. Cheung WW, Mak RH. 2010. Ghrelin in chronic kidney disease. Int J Pept 2010:567343.
8. Creutzberg EC, Wouters EF, Vanderhoven-Augustin IM, Dentener MA, Schols AM. 2000. Disturbances in leptin metabolism are related to energy imbalance during acute exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 162:1239-1245.
9. Croce K, Gao H, Wang Y, Mooroka T, Sakuma M, Shi C, Sukhova GK, Packard RR, Hogg N, Libby P, Simon DI. 2009. Myeloid-related protein-8/14 is critical for the biological response to vascular injury. Circulation 120:427-436.
10. Danesh J, Wheeler JG, Hirschfield GM, Eda S, Eiriksdottir G, Rumley A, Lowe GD, Pepys MB, Gudnason V. 2004. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 350:1387-1397. (Pubitemid 38419992)
11. Eisen SA, Lyons MJ, Goldberg J, True WR. 1993. The impact of cigarette and alcohol consumption on weight and obesity. An analysis of 1911 monozygotic male twin pairs. Arch Intern Med 153:2457-2463. (Pubitemid 23319872)
12. Foell D, Roth J. 2004. Proinflammatory S100 proteins in arthritis and autoimmune disease. Arthritis Rheum 50:3762-3771. (Pubitemid 39643922)
13. Fernandez-Real JM, Broch M, Vendrell J, Ricart W. 2003. Smoking, fat mass and activation of the tumor necrosis factor-alpha pathway. Int J Obes Relat Metab Disord 27:1552-1556. (Pubitemid 38019171)
14. Frankham P, Cabanac M. 2003. Nicotine lowers the body-weight setpoint in male rats. Appetite 41:1-5. (Pubitemid 37490772)
15. Gray RD, Imrie M, Boyd AC, Porteous D, Innes JA, Greening AP. 2010. Sputum and serum calprotectin are useful biomarkers during CF exacerbation. J Cyst Fibros 9:193-198.
16. Hajek P, Jackson P, Belcher M. 1988. Long-term use of nicotine chewing gum. Occurrence, determinants, and effect on weight gain. JAMA 260:1593-1596.
17. Hamilton BS, Paglia D, Kwan AY, Deitel M. 1995. Increased obese mRNA expression in omental fat cells from massively obese humans. Nat Med 1:953-956.
18. Hansel NN, Gao L, Rafaels NM, Mathias RA, Neptune ER, Tankersley C, Grant AV, Connett J, Beaty TH, Wise RA, Barnes KC. 2009. Leptin receptor polymorphisms and lung function decline in COPD. Eur Respir J 34:103-110.
19. Healy AM, Pickard MD, Pradhan AD, Wang Y, Chen Z, Croce K, Sakuma M, Shi C, Zago AC, Garasic J, Damokosh AI, Dowie TL, Poisson L, Lillie J, Libby P, Ridker PM, Simon DI. 2006. Platelet expression profiling and clinical validation of myeloid-related protein-14 as a novel determinant of cardiovascular events. Circulation 113:2278-2284. (Pubitemid 43947973)
20. Ikonomidis I, Lekakis J, Vamvakou G, Andreotti F, Nihoyannopoulos P. 2005. Cigarette smoking is associated with increased circulating proinflammatory and procoagulant markers in patients with chronic coronary artery disease: effects of aspirin treatment. Am Heart J 149:832-839. (Pubitemid 40718878)
21. Jessen A, Buemann B, Toubro S, Skovgaard IM, Astrup A. 2005. The appetite-suppressant effect of nicotine is enhanced by caffeine. Diabetes Obes Metab 7:327-333. (Pubitemid 40916574)
22. Jo YH, Talmage DA, Role LW. 2002. Nicotinic receptor-mediated effects on appetite and food intake. J Neurobiol 53:618-632. (Pubitemid 35375591)
23. Kokkinos A, Tentolouris N, Kyriakaki E, Argyrakopoulou G, Doupis J, Psallas M, Kyriaki D, Katsilambros N. 2007. Differentiation in the short-and long-term effects of smoking on plasma total ghrelin concentrations between male nonsmokers and habitual smokers. Metab Clin Exp 56:523-527. (Pubitemid 46427850)
24. Mooren FC, Lechtermann A, Fobker M, Brandt B, Sorg C, Völker K, Nacken W. 2006. The response of the novel pro-inflammatory molecules S100A8/A9 to exercise. Int J Sports Med 27:751-758. (Pubitemid 44369574)
25. Mortensen OH, Nielsen AR, Erikstrup C, Plomgaard P, Fischer CP, Krogh-Madsen R, Lindegaard B, Petersen AM, Taudorf S, Pedersen BK. 2009. Calprotectin-a novel marker of obesity. PLoS ONE 4:e7419.
26. Nagel G, Arnold FJ, Wilhelm M, Link B, Zoellner I, Koenig W. 2009. Environmental tobacco smoke and cardiometabolic risk in young children: results from a survey in south-west Germany. Eur Heart J 30:1885-1893.
27. Otero M, Nogueiras R, Lago F, Dieguez C, Gomez-Reino JJ, Gualillo O. 2004. Chronic inflammation modulates ghrelin levels in humans and rats. Rheumatology (Oxford) 43:306-310. (Pubitemid 38313178)
28. Perkins KA. 1992. Metabolic effects of cigarette smoking. J Appl Physiol 72:401-409.
29. Roth J, Goebeler M, Sorg C. 2001. S100A8 and S100A9 in inflammatory diseases. Lancet 357:1041.
30. Saad A, Abbas OA. 2009. Ghrelin as a regulator of gonadal function in adult male offsprings exposed to cigarette smoking in utero. Endocr Regul 43:141-148.
31. Schwartz MW, Woods SC, Porte D Jr, Seeley RJ, Baskin DG. 2000. Central nervous system control of food intake. Nature 404:661-671. (Pubitemid 30205071)
32. Stríz I, Trebichavský I. 2004. Calprotectin-a pleiotropic molecule in acute and chronic inflammation. Physiol Res 53:245-253. (Pubitemid 38797280)
33. Sztalryd C, Hamilton J, Horwitz BA, Johnson P, Kraemer FB. 1996. Alterations of lipolysis and lipoprotein lipase in chronically nicotine-treated rats. Am J Physiol 270:E215-E223.
34. Thaqi A, Franke K, Merkel G, Wichmann HE, Heinrich J. 2005. Biomarkers of exposure to passive smoking of school children: frequency and determinants. Indoor Air 15:302-310. (Pubitemid 41219464)
35. Wager-Srdar SA, Levine AS, Morley JE, Hoidal JR, Niewoehner DE. 1984. Effects of cigarette smoke and nicotine on feeding and energy. Physiol Behav 32:389-395. (Pubitemid 14148109)
36. Wells JC. 2000. A Hattori chart analysis of body mass index in infants and children. Int J Obes Relat Metab Disord 24:325-329. (Pubitemid 30137723)